News Agency
The Times

Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

  • Written by PR Newswire
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

Highlights

  • Clarity recently reported that in its diagnostic Phase 1/2 trial, COBRA, 64Cu-SAR-bisPSMA was found to be safe and highly effective in detecting prostate cancer (PC) lesions in patients with biochemical recurrence (BCR).
  • In trial participants where standard of care (SOC) imaging was unable to detect any lesions, up to approximately...

Read more: Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion